Stephen V Liu/X
Feb 3, 2025, 16:55
Stephen Liu: The KRAS G12C space in NSCLC at ITCD2025
Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Dr. Natasha Leighl discusses the KRAS G12C space in NSCLC at ITCD2025.
Sotorasib and adagrasib are our approved options but others in development. Will combinations emerge as the best strategy. The heterogeneity within G12C is very striking to me.”
More posts featuring Stephen Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34